Veterinary Medicines

Buscopan compositum vet. injektioneste, liuos hevosille

Not authorised
  • Hyoscine butylbromide
  • Metamizole sodium
Download as PDF

Product identification

Medicine name:
Buscopan compositum vet. injektioneste, liuos hevosille
Active substance:
  • Hyoscine butylbromide
  • Metamizole sodium
Target species:
  • Horse
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Hyoscine butylbromide
    4.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Metamizole sodium
    500.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Horse
      • Meat and offal
        9
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA03DB04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Finland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
  • Labiana Life Sciences S.A.
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 12024
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 27/01/2022
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 21/06/2022
Download